134 related articles for article (PubMed ID: 1831356)
1. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice.
Lukic ML; Stosic-Grujicic S; Ostojic N; Chan WL; Liew FY
Biochem Biophys Res Commun; 1991 Aug; 178(3):913-20. PubMed ID: 1831356
[TBL] [Abstract][Full Text] [Related]
2. Administration of NG-monomethyl-L-arginine in a marginal renal subcapsular mouse islet transplant model.
Ansite JD; Stevens RB; Lokeh A; Brown RR; Saxena M; Mills CD; Sutherland DE
Transplant Proc; 1995 Feb; 27(1):605-6. PubMed ID: 7879115
[No Abstract] [Full Text] [Related]
3. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice.
Papaccio G; Esposito V; Latronico MV; Pisanti FA
Int J Pancreatol; 1995 Feb; 17(1):63-8. PubMed ID: 8568336
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
[TBL] [Abstract][Full Text] [Related]
8. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
9. Administration of L-GN-monomethyl-arginine in a mouse islet transplant model.
Stevens RB; Ansite JD; Lokeh A; Saxena M; Mills CD; Sutherland DE
Transplant Proc; 1994 Dec; 26(6):3363. PubMed ID: 7998175
[No Abstract] [Full Text] [Related]
10. Inhibition of nitric oxide generation: normalization of in vitro insulin secretion in mice with multiple low-dose streptozotocin and in mice injected with mononuclear splenocytes from diabetic syngeneic donors.
Karabatas LM; Fabiano de Bruno L; Pastorale CF; Cullen C; Basabe JC
Metabolism; 1996 Aug; 45(8):940-6. PubMed ID: 8769348
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
Naess PA; Kirkebøen KA; Christensen G; Kiil F
Am J Physiol; 1992 Jun; 262(6 Pt 2):F939-42. PubMed ID: 1535755
[TBL] [Abstract][Full Text] [Related]
12. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
[TBL] [Abstract][Full Text] [Related]
14. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
Weide LG; Lacy PE
Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
16. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.
Liew FY; Millott S; Parkinson C; Palmer RM; Moncada S
J Immunol; 1990 Jun; 144(12):4794-7. PubMed ID: 2351828
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide is important for mouse beta-cell line killing by peritoneal exudate cells obtained from cyclophosphamide treated non-obese diabetic mice.
Kasuga A; Nakaki T; Takei I; Takayama S; Ozawa Y; Maruyama T; Miyazaki J; Saruta T
Endocr J; 1995 Apr; 42(2):259-63. PubMed ID: 7542976
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine.
Liew FY; Li Y; Millott S
Immunology; 1990 Dec; 71(4):556-9. PubMed ID: 2279740
[TBL] [Abstract][Full Text] [Related]
19. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-gamma plus tumor necrosis factor-alpha.
Yamada K; Otabe S; Inada C; Takane N; Nonaka K
Biochem Biophys Res Commun; 1993 Nov; 197(1):22-7. PubMed ID: 7504484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
